E-ISSN 2636-834X
 
2023, Vol: 13, Issue: 1
13/1Current Issue Online FirstArchiveAims and ScopeAbstracting & IndexingMost Accessed ArticlesMost Downloaded ArticlesMost Cited Articles
Required files to be uploaded

COPYRIGHT FORM

Case Report 


Varenicline-induced manic episode

Omer Gecici, Melike Nebioglu, Mukerrem Guven.

Cited By: 1

Abstract
Varenicline is a novel antismoking agent that reduces cravings and blocks pleasure of nicotine by serving as a partial agonist to the nicotinic receptor Varenicline has been associated with some important psychiatric adverseeffects for the patients with psychiatric history. However, varenicline related manic episode has not been reported for patients with no psychiatric history. In this study, firstly a manic episode case with psychotic features developed in an individual with no psychiatric and family psychiatric history is described.

Key words: Keywords: Varenicline, Mania, Nicotine


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Omer Gecici
Articles by Melike Nebioglu
Articles by Mukerrem Guven
on Google
on Google Scholar


REFERENCES
1. Rosecrans JA: The biobehavioral effects of nicotine: interaction with brain neurochemical systems, in The Clinical Management of Nicotine Dependence. Edited by Cocores JA. New York, Springer-Verlag, 1991,pp 53-653.
2. Kohen I, Kremen N. Varenicline-induced manic episode in a patient with bipolar disorder. Am J Psychiatry. 2007;164:1269-1270. [DOI via Crossref]    [Pubmed]   
3. Food and Drug Administration. FDA Med Watch Alert, Varenicline (marketed as Chantix): Information, February 1, 2008, and November 20, 2007. Available at www.fda.gov/cder/drug/infopage/varenicline/default.htm. Accessed April 20, 2008.
4. Freedman R. Exacerbation of schizophrenia by varenicline [letter]. Am J Psychiatry. 2007;164:1269. [DOI via Crossref]    [Pubmed]   
5. Pumariega AJ, Nelson R, Rotenberg L, Varenicline-induced mixed mood and psychotic episode in a patient with a past history of depression. CNS Spectr. 2008;13(6):511-514. 7. Coe J, Brooks P, Vertelino M, et al. Varenicline: an α4β2 nicotinic receptor partial agonist for smoking cessation. J Med Chem. 2005;48:3474-3477.
6. Coe J, Brooks P, Vertelino M, et al. Varenicline: an α4β2 nicotinic receptor partial agonist for smoking cessation. J Med Chem. 2005;48:3474-3477. [DOI via Crossref]    [Pubmed]   
7. Gonzales D, Rennard S, Nides M, et al. Varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs. sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. JAMA. 2006;296:47-55.
8. Jorenby DE, Hays JR, Rigotti NA, et al. Efficacy of varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs. placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. JAMA. 2006;296:56-63.
9. Tonstad S, Tonnesen P, Hajek P, et al. Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial. JAMA. 2006;296:64-71. [DOI via Crossref]    [Pubmed]   
10. Fadi Alhatem, MD and James E. Black, MD, PhD. Varenicline-Induced Mania in a Bipolar Patient. Clin Neuropharm 2009;32: 117-118. [DOI via Crossref]    [Pubmed]   

This Article Cited By the following articles

First episode mania following cessation of varenicline (Champix)
Australas Psychiatry 2016; 24(3): 292.

1
 
How to Cite this Article
Pubmed Style

Omer Gecici, Melike Nebioglu, Mukerrem Guven. Varenicline-induced manic episode. PBS. 2012; 2(2): 74-76. doi:10.5455/jmood.20120516035249

Web Style

Omer Gecici, Melike Nebioglu, Mukerrem Guven. Varenicline-induced manic episode. https://www.pbsciences.org/?mno=16238 [Access: April 25, 2023]. doi:10.5455/jmood.20120516035249

AMA (American Medical Association) Style

Omer Gecici, Melike Nebioglu, Mukerrem Guven. Varenicline-induced manic episode. PBS. 2012; 2(2): 74-76. doi:10.5455/jmood.20120516035249


Vancouver/ICMJE Style

Omer Gecici, Melike Nebioglu, Mukerrem Guven. Varenicline-induced manic episode. PBS. (2012), [cited April 25, 2023]; 2(2): 74-76. doi:10.5455/jmood.20120516035249


Harvard Style

Omer Gecici, Melike Nebioglu, Mukerrem Guven (2012) Varenicline-induced manic episode. PBS, 2 (2), 74-76. doi:10.5455/jmood.20120516035249


Turabian Style

Omer Gecici, Melike Nebioglu, Mukerrem Guven. 2012. Varenicline-induced manic episode. Psychiatry and Behavioral Sciences, 2 (2), 74-76. doi:10.5455/jmood.20120516035249


Chicago Style

Omer Gecici, Melike Nebioglu, Mukerrem Guven. "Varenicline-induced manic episode." Psychiatry and Behavioral Sciences 2 (2012), 74-76. doi:10.5455/jmood.20120516035249


MLA (The Modern Language Association) Style

Omer Gecici, Melike Nebioglu, Mukerrem Guven. "Varenicline-induced manic episode." Psychiatry and Behavioral Sciences 2.2 (2012), 74-76. Print. doi:10.5455/jmood.20120516035249


APA (American Psychological Association) Style

Omer Gecici, Melike Nebioglu, Mukerrem Guven (2012) Varenicline-induced manic episode. Psychiatry and Behavioral Sciences, 2 (2), 74-76. doi:10.5455/jmood.20120516035249


Author LoginReviewer Login
This is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission from the publisher or the author. This is in accordance with the Budapest Open Access Initiative (BOAI) definition of open access.
The articles in Psychiatry and Behavioral Sciences are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc-sa/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
Copyright © 2023 Psychiatry and Behavioral Sciences All Rights Reserved. Subject to change without notice from or liability to Psychiatry and Behavioral Sciences.
For best results, please use Internet Explorer or Google Chrome

Contact Information